Ventricular Assist Device Market
Ventricular Assist Device Market Forecasts to 2030 - Global Analysis By Product Type (Right Ventricular Assist Device, Left Ventricular Assist Device, Bi-Ventricular Assist Device and Total Artificial Heart), Type Of Flow, Design, Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1.29 BN |
|
Projected Year Value (2030) |
US $3.01BN |
|
CAGR (2023 - 2030) |
12.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Ventricular Assist Device Market is accounted for $1.29 billion in 2023 and is expected to reach $3.01 billion by 2030 growing at a CAGR of 12.8% during the forecast period. A mechanical pump called a Ventricular Assist Device (VAD) is inserted either within or outside the body to help a weak or failing heart pump blood throughout the body. These devices are mostly used as a bridge to heart transplantation, destination treatment for patients not suitable for transplantation, or, in certain circumstances, as a bridge to recovery in patients with severe heart failure.
According to the World Health Organization 2021, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke.
Market Dynamics:
Driver:
Surge in the prevalence of chronic conditions
An increase in long-term illnesses that lead to advanced heart failure is one factor driving up demand for ventricular assist device. Heart failure can be caused by a number of chronic illnesses, including diabetes, hypertension, and coronary artery disease. As a result, more individuals will need sophisticated cardiac care. Heart failure care may need to be longer and more intensive if chronic diseases that contribute to heart failure are more common. This may mean that more patients may need this therapy indefinitely, or that more patients who are not candidates for heart transplantation will need thus driving the growth of the market
Restraint:
High cost
Patients' access may be restricted by the high cost of ventricular assist device therapy, which includes follow-up therapies, surgical procedures, post-implantation care, and device fees. Financial limitations may impede certain persons from accessing this life-saving therapy because of its exorbitant expenses. Variations in healthcare systems and economic situations among various areas or nations may give rise to disparities in the accessibility of this treatment. Moreover, this treatment may be difficult to get to those in need in areas with a poor healthcare infrastructure or low financial resources which hamper the market growth.
Opportunity:
Increasing risks of organ failures
Ventricular Assist Device and other advanced cardiac support therapies are in greater demand as the chances of organ failures, particularly cardiac failure, and rise owing to aging populations, changing lifestyles, and the frequency of chronic illnesses. An increasing number of people are at risk for serious cardiac disorders due to the rising risks of organ failure, particularly heart failure. The number of people who would need this treatment to treat advanced heart failure rises as a result of this patient pool expansion.
Threat:
Compromised device reliability and durability
Patients' and doctors' confidence in selecting ventricular assist device therapy may be impacted by worries regarding the longevity and dependability of the device. Fear of device failure or malfunction may cause patients to hesitate or be reluctant to choose this treatment, which may have an adverse effect on patient acceptability. Furthermore, investment in R&D projects targeted at advancing VAD technology may be impacted by enduring worries about the dependability and durability of the devices. Innovation in the industry may be hampered by a lack of funding or a decline in enthusiasm in creating new gadgets impeding the market growth.
Covid-19 Impact
Many hospitals and healthcare institutions encountered difficulties in allocating resources, giving priority to urgent cases, and curtailing non-essential treatments during the peak times of the epidemic. It's possible that elective procedures, such as certain ventricular assist device implantations or regular follow-ups, were postponed or delayed, which momentarily affected the market. Disruptions in the worldwide supply chain, including production and delivery, may have affected the accessibility and conveyance of these parts, apparatus, or associated machinery. These hiccups can have an impact on when ventricular assist device are purchased and installed.
The right ventricular assist device segment is expected to be the largest during the forecast period
The right ventricular assist device segment is estimated to have a lucrative growth, as it one kind of Ventricular Assist Device (VAD) made expressly to support the right ventricle of the heart is the Right Ventricular Assist Device (RVAD). The RVAD is generally focused on helping the right side of the heart, while other VADs are designed to support the left ventricle (Left Ventricular support Device, or LVAD) or both ventricles (BiVAD). The goal of ongoing research and technological developments in VADs is to improve patient outcomes, decrease problems, and strengthen the endurance of RVADs while addressing issues unique to sustaining the right ventricle.
The implantable ventricular assist device segment is expected to have the highest CAGR during the forecast period
The implantable ventricular assist device segment is anticipated to witness the highest CAGR growth during the forecast period. Mechanical pumps called Implantable Ventricular Assist Devices (VADs) are surgically inserted within the body to help the heart pump blood. These devices, which provide assistance to those with severe heart failure or that awaiting heart transplantation, are an essential part of the market for ventricular assist devices. The quality of life is enhanced, exercise capacity is boosted, heart failure symptoms are relieved, and patients with severe heart failure have a longer chance of survival due to these devices.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period as heart failure is becoming more common in the Asia Pacific area as a result of aging populations, changes in lifestyle, and an increase in cardiovascular disorders. The increased need for ventricular assist device as a therapy option is a result of the rise in heart failure cases. Every nation in the Asia-Pacific area is making investments in the expansion of its healthcare infrastructure, including modernizing its facilities for cutting-edge cardiac treatment. A number of major medical device companies have been concentrating on joining and growing in the Asia Pacific this market.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, because heart failure is becoming more common in Europe, as it is in many other parts of the world. The need for ventricular assist device as a therapy option for individuals with advanced heart failure has increased as a result of the growth in heart failure cases. Moreover, this technology has been improving and is now available in the European market. Constant innovation aims to improve patient outcomes, lower problems related to VAD therapy, and create more compact, robust, and effective devices driving the growth of the market.
Key players in the market
Some of the key players profiled in the Ventricular Assist Device Market include Corewave SA, SynCardia Systems, AdjuCor GmbH, Bivacor Inc, LivaNova PLC, Windmill Cardiovascular Systems, Calon Cardio-Technology Ltd, Abiomed, Inc., Fineheart, Abbott Laboratories, Evaheart, Inc.,Berlin Heart GmbH, Carmat SA, Medtronic, Jarvik Heart, Inc., ReliantHeart, Sun Medical Technology Research Corp, Thoratec Corporation and CardiacAssist, Inc
Key Developments:
In November 2023, Sun Medical Technology Research Corp. announced that it has received ¥2 billion in funding from Hi-Lex Corporation. The investor will hold 66.7% stake in the company through this transaction.
In September 2023, CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris. The company occupies over 2,400m² of production, laboratory, and office space, bringing together its headquarters, R&D center and its first manufacturing facility of almost 1,000m².
Product Types Covered:
• Right Ventricular Assist Device
• Left Ventricular Assist Device
• Bi-Ventricular Assist Device
• Total Artificial Heart
Type Of Flows Covered:
• Pulsatile Flow
• Continuous Flow
Designs Covered:
• Implantable Ventricular Assist Device
• Transcutaneous Ventricular Assist Device
Applications Covered:
• Bridge-To-Recovery (BTR)
• Destination Therapy
• Bridge-To-Transplant (BTT)
• Bridge To Candidacy Therapy
End Users Covered:
• Hospitals
• Home Care Setups
• Ambulatory Care Center
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Ventricular Assist Device Market, By Product Type
5.1 Introduction
5.2 Right Ventricular Assist Device
5.3 Left Ventricular Assist Device
5.4 Bi-Ventricular Assist Device
5.5 Total Artificial Heart
6 Global Ventricular Assist Device Market, By Type Of Flow
6.1 Introduction
6.2 Pulsatile Flow
6.3 Continuous Flow
7 Global Ventricular Assist Device Market, By Design
7.1 Introduction
7.2 Implantable Ventricular Assist Device
7.3 Transcutaneous Ventricular Assist Device
8 Global Ventricular Assist Device Market, By Application
8.1 Introduction
8.2 Bridge-To-Recovery (BTR)
8.3 Destination Therapy
8.4 Bridge-To-Transplant (BTT)
8.5 Bridge To Candidacy Therapy
9 Global Ventricular Assist Device Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Home Care Setups
9.4 Ambulatory Care Center
9.5 Other End Users
10 Global Ventricular Assist Device Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Corewave SA
12.2 SynCardia Systems
12.3 AdjuCor GmbH
12.4 Bivacor Inc
12.5 LivaNova PLC
12.6 Windmill Cardiovascular Systems
12.7 Calon Cardio-Technology Ltd
12.8 Abiomed, Inc.
12.9 Fineheart
12.10 Abbott Laboratories
12.11 Evaheart, Inc.,
12.12 Berlin Heart GmbH
12.13 Carmat SA
12.14 Medtronic
12.15 Jarvik Heart, Inc.
12.16 ReliantHeart
12.17 Sun Medical Technology Research Corp
12.18 Thoratec Corporation
12.19 CardiacAssist, Inc
List of Tables
1 Global Ventricular Assist Device Market Outlook, By Region (2021-2030) ($MN)
2 Global Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
4 Global Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
5 Global Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
6 Global Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
7 Global Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
8 Global Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
9 Global Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
10 Global Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
11 Global Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
12 Global Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
13 Global Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
14 Global Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
15 Global Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
16 Global Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
17 Global Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
18 Global Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
19 Global Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
20 Global Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
21 Global Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
22 Global Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
23 North America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
24 North America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
25 North America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
26 North America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
27 North America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
28 North America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
29 North America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
30 North America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
31 North America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
32 North America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
33 North America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
34 North America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
35 North America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
36 North America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
37 North America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
38 North America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
39 North America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
40 North America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
41 North America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
42 North America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
43 North America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
44 North America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
45 Europe Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
46 Europe Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
47 Europe Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
48 Europe Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
49 Europe Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
50 Europe Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
51 Europe Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
52 Europe Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
53 Europe Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
54 Europe Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
55 Europe Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
56 Europe Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
57 Europe Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
58 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
59 Europe Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
60 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
61 Europe Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
62 Europe Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
63 Europe Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
64 Europe Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
65 Europe Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
66 Europe Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
67 Asia Pacific Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
69 Asia Pacific Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
70 Asia Pacific Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
71 Asia Pacific Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
72 Asia Pacific Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
73 Asia Pacific Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
74 Asia Pacific Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
75 Asia Pacific Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
76 Asia Pacific Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
77 Asia Pacific Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
78 Asia Pacific Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
79 Asia Pacific Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
80 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
81 Asia Pacific Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
82 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
83 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
84 Asia Pacific Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
85 Asia Pacific Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
86 Asia Pacific Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
87 Asia Pacific Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
88 Asia Pacific Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
89 South America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
90 South America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
91 South America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
92 South America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
93 South America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
94 South America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
95 South America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
96 South America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
97 South America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
98 South America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
99 South America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
100 South America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
101 South America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
102 South America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
103 South America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
104 South America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
105 South America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
106 South America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
107 South America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
108 South America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
109 South America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
110 South America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
111 Middle East & Africa Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
113 Middle East & Africa Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
114 Middle East & Africa Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
115 Middle East & Africa Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
116 Middle East & Africa Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
117 Middle East & Africa Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
118 Middle East & Africa Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
119 Middle East & Africa Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
120 Middle East & Africa Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
121 Middle East & Africa Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
122 Middle East & Africa Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
123 Middle East & Africa Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
124 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
125 Middle East & Africa Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
126 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
127 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
128 Middle East & Africa Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
129 Middle East & Africa Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
130 Middle East & Africa Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
131 Middle East & Africa Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
132 Middle East & Africa Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
